Mellitus, E. t. D. (2012). Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus. Endocrinology Research Centre.
Cita Chicago Style (17a ed.)Mellitus, Editorial team Diabetes. Expert Committee on Novel DPP-4 Inhibitor TRADJENTA (linagliptin) in Treatment of Type 2 Diabetes Mellitus. Endocrinology Research Centre, 2012.
Cita MLA (8a ed.)Mellitus, Editorial team Diabetes. Expert Committee on Novel DPP-4 Inhibitor TRADJENTA (linagliptin) in Treatment of Type 2 Diabetes Mellitus. Endocrinology Research Centre, 2012.
Precaución: Estas citas no son 100% exactas.